[go: up one dir, main page]

CL2012002246A1 - Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos. - Google Patents

Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos.

Info

Publication number
CL2012002246A1
CL2012002246A1 CL2012002246A CL2012002246A CL2012002246A1 CL 2012002246 A1 CL2012002246 A1 CL 2012002246A1 CL 2012002246 A CL2012002246 A CL 2012002246A CL 2012002246 A CL2012002246 A CL 2012002246A CL 2012002246 A1 CL2012002246 A1 CL 2012002246A1
Authority
CL
Chile
Prior art keywords
extract
allergen extract
allergen
vaccine
produce
Prior art date
Application number
CL2012002246A
Other languages
English (en)
Inventor
Sanchez Jeronimo Carnes
Original Assignee
Leti Sl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti Sl Lab filed Critical Leti Sl Lab
Publication of CL2012002246A1 publication Critical patent/CL2012002246A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Proceso para producir un extracto de alérgenos; extracto de alérgenos; uso de un extracto de alérgenos para tratar alergia a los cacahuetes; composición farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alérgenos.
CL2012002246A 2010-02-12 2012-08-13 Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos. CL2012002246A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201030199 2010-02-12

Publications (1)

Publication Number Publication Date
CL2012002246A1 true CL2012002246A1 (es) 2013-05-24

Family

ID=43760024

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012002246A CL2012002246A1 (es) 2010-02-12 2012-08-13 Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos.

Country Status (17)

Country Link
US (3) US9884111B2 (es)
EP (2) EP2533808B1 (es)
JP (3) JP5969922B2 (es)
CN (2) CN104371016B (es)
AU (1) AU2011214316B2 (es)
BR (1) BR112012019848B1 (es)
CA (2) CA3060638A1 (es)
CL (1) CL2012002246A1 (es)
CO (1) CO6602140A2 (es)
EC (1) ECSP12012102A (es)
ES (2) ES2676058T3 (es)
MX (1) MX2012009267A (es)
PE (1) PE20130044A1 (es)
PL (2) PL2533808T3 (es)
PT (2) PT2533808E (es)
RU (2) RU2706685C2 (es)
WO (1) WO2011098569A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2533808T3 (pl) 2010-02-12 2015-03-31 Laboratorios Leti S L Sposób produkcji oczyszczonego ekstraktu z alergenu
DK2875828T3 (da) * 2012-07-20 2019-07-01 Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S A Sammensætning til intradermal indgivelse af polymeriserede allergener
CN104447943A (zh) * 2014-11-21 2015-03-25 浙江我武生物科技股份有限公司 一种提取狗毛皮屑变应原的方法
BR112020002023A2 (pt) * 2017-07-31 2020-10-06 Laboratorios Leti S.L. Unipersonal extrato veterinário alergênico de ácaro, processo para produzir um extrato veterinário alergênico de ácaro, composição farmacêutica e vacina
US11408895B1 (en) 2018-04-09 2022-08-09 Hob Biotech Group Corp., Ltd. Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay
BR112021014064A2 (pt) * 2019-01-17 2021-09-21 LETI Pharma S.L. Processo para produção de um extrato alergênico despigmentado, extrato alergênico despigmentado, extrato alergênico despigmentado polimerizado, composição farmacêutica, e vacina
CN113817037A (zh) * 2021-10-29 2021-12-21 南昌大学 一种从生腰果中制备高纯度致敏原Ana o 3的方法
CN115032406A (zh) * 2022-07-04 2022-09-09 郑州安图生物工程股份有限公司 检测试剂及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463740A (en) 1946-03-29 1949-03-08 Raymond S Burnett Preparation of peanut protein free from peanut skin pigment
GB1283989A (en) 1969-12-15 1972-08-02 Omega Lab Ltd Allergenic extracts and method for their preparation
US4234569A (en) * 1978-10-04 1980-11-18 The Johns Hopkins University Production of aldehyde-treated allergen-containing substances
JPS5645417A (en) 1979-09-19 1981-04-25 Mochida Pharmaceut Co Ltd Pharmaceutical composition having antiallergic activity
EP0083497A3 (en) 1982-01-06 1985-11-06 Beecham Group Plc Process for preparing modified allergens, their use in treating allergic conditions
US4716120A (en) * 1983-03-17 1987-12-29 Minnesota Mining And Manufacturing Company Stable allergenic extracts and methods
ES2013359A6 (es) 1988-11-04 1990-05-01 Corporacion Biolog Farmaceutic Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
JPH06507494A (ja) * 1991-04-26 1994-08-25 カレノフ，エマニユエル 細菌性アレルゲンにより惹起される疾患の検出及び治療方法
US5770698A (en) 1992-09-21 1998-06-23 C.B.F. Leti S.A. Process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
JP3397791B2 (ja) 1992-09-21 2003-04-21 ラボラトリオス レティ ソシエダッド アノニマ アレルゲンとして活性なタンパク質を含有する水性エキスの精製方法，この方法で得られるエキスならびにそれらの使用
EP1360297A2 (en) 2001-02-05 2003-11-12 The Regents Of The University Of California Ragweed allergens
US7332289B2 (en) * 2001-03-09 2008-02-19 Chugai Seiyaku Kabushiki Kaisha Method of purifying protein
RU2205661C2 (ru) * 2001-07-13 2003-06-10 Петров Рем Викторович Аллерготропин для лечения полинозов и способ лечения полинозов
CN1430052A (zh) * 2001-12-31 2003-07-16 合富生化科技股份有限公司 过敏原检测芯片
FR2841906B1 (fr) * 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
WO2004092393A1 (en) * 2003-01-09 2004-10-28 Genentech, Inc. Purification of polypeptides
ATE307141T1 (de) 2003-01-21 2005-11-15 Biomay Prod & Handel Verfahren zur vorbereitung von hypoallergenen mosaikproteine
DK1834648T3 (da) 2006-03-14 2013-11-04 Alk Abello As Fremgangsmåde til fremstilling af et allergenekstrakt
EP1834649A1 (en) 2006-03-14 2007-09-19 Alk-Abello A/S Method of developing a process for producing an allergen extract
US7887821B2 (en) * 2007-12-20 2011-02-15 Alk-Abello A/S Process for producing an allergen extract
PL2533808T3 (pl) 2010-02-12 2015-03-31 Laboratorios Leti S L Sposób produkcji oczyszczonego ekstraktu z alergenu

Also Published As

Publication number Publication date
PT2533808E (pt) 2014-11-28
RU2706685C2 (ru) 2019-11-20
ES2676058T3 (es) 2018-07-16
JP6646480B2 (ja) 2020-02-14
EP2533808B1 (en) 2014-08-20
ES2395093T3 (es) 2014-12-22
CN102821785A (zh) 2012-12-12
BR112012019848A2 (pt) 2020-07-07
EP2853271B1 (en) 2018-04-04
CN104371016A (zh) 2015-02-25
CN104371016B (zh) 2018-05-15
JP2016145235A (ja) 2016-08-12
RU2015149538A3 (es) 2019-05-08
CA3060638A1 (en) 2011-08-18
WO2011098569A1 (en) 2011-08-18
PL2853271T3 (pl) 2018-09-28
AU2011214316A1 (en) 2012-08-16
WO2011098569A9 (en) 2012-03-15
ES2395093T1 (es) 2013-02-08
US20180200363A1 (en) 2018-07-19
JP2013519656A (ja) 2013-05-30
AU2011214316B2 (en) 2015-07-02
CN102821785B (zh) 2014-12-10
PE20130044A1 (es) 2013-02-14
MX2012009267A (es) 2013-02-07
US20180200362A1 (en) 2018-07-19
EP2533808A1 (en) 2012-12-19
CA2789174A1 (en) 2011-08-18
US11246923B2 (en) 2022-02-15
US9884111B2 (en) 2018-02-06
RU2012134032A (ru) 2014-03-20
JP5969922B2 (ja) 2016-08-17
EP2853271A1 (en) 2015-04-01
US20150306211A1 (en) 2015-10-29
CO6602140A2 (es) 2013-01-18
PT2853271T (pt) 2018-07-09
RU2015149538A (ru) 2019-01-15
RU2572230C2 (ru) 2015-12-27
CA2789174C (en) 2021-08-24
PL2533808T3 (pl) 2015-03-31
JP2017226687A (ja) 2017-12-28
BR112012019848B1 (pt) 2022-03-15
ECSP12012102A (es) 2013-04-30

Similar Documents

Publication Publication Date Title
CL2012002246A1 (es) Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos.
CL2014001291A1 (es) Agentes de iarn de doble hebra; composiciones y metodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr).
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
AR091700A1 (es) Anticuerpos e inmunoconjugados anti-cd79b
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
PE20151067A1 (es) Inhibidores de autotaxina
CR20120184A (es) Anticuerpos monoclonales frente a progastrina y su usos
CL2014000183A1 (es) Formulación farmacéutica que contienen anticuerpos anti-pcsk9; metodo para preparar dicha formulación.
CR20130033A (es) Formulaciones de rifaximina y usos de las mismas
PE20150646A1 (es) Metodos de tratamiento de una tauopatia
UY35467A (es) Compuestos orgánicos
MX353827B (es) Formas de rifaximina y usos de la misma.
BR112013029773A2 (pt) canabinoides para uso no tratamento de dor neuropática
BR112014009837A2 (pt) uso eficaz da levedura e extrato de levedura
CO7020907A2 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
BR112013031493A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto.
MX2018008597A (es) Composiciones inyectables de melfalan que comprenden un derivado de ciclodextrina y metodos de fabricacion y uso de las mismas.
CL2015002724A1 (es) Métodos para tratar la enfermedad de crohn utilizando un anticuerpo anti-il23
GT201400090A (es) 2-tiopirimidinonas
DOP2012000279A (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona
UY33909A (es) Metodo para producir fibra de lignina
ES2408343R1 (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
CL2011002258A1 (es) Compuestos derivados heterociclicos fusionados; composicion farmaceutica que los comprende; y uso de los compuestos para tratar vih.
MX2015003039A (es) Proceso para la reducción de derivados nitro a aminas.
CO6721048A2 (es) Anticuerpos que se unen a notum pectinacetilesterasa